Peter Attia· MD
we wound up making a vaccine manufacturing it that showed pretty good levels of high levels of efficacy and seemed to get around the problem with immune enhancement
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we wound up making a vaccine manufacturing it that showed pretty good levels of high levels of efficacy and seemed to get around the problem with immune enhancement
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
if they only use the receptor binding domain the smallest part of the S protein the docks with the receptor the acetylcholine ACE 2 receptor in the lungs they seem to get protection in laboratory animals without all the immune enhancement